{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:28:19Z","timestamp":1793384899441,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM103641"],"award-info":[{"award-number":["GM103641"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI155887"],"award-info":[{"award-number":["R01AI155887"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI142409"],"award-info":[{"award-number":["R21AI142409"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucosal antibodies maintain gut homeostasis by promoting spatial segregation between host tissues and luminal microbes. Whether and how mucosal antibody responses influence gut health through modulation of microbiota composition is unclear. Here, we use a CD19<jats:sup>\u2212\/\u2212<\/jats:sup> mouse model of antibody-deficiency to demonstrate that a relationship exists between dysbiosis, defects in bile acid homeostasis, and gluten-sensitive enteropathy of the small intestine. The gluten-sensitive small intestine enteropathy that develops in CD19<jats:sup>\u2212\/\u2212<\/jats:sup> mice is associated with alterations to luminal bile acid composition in the SI, marked by significant reductions in the abundance of conjugated bile acids. Manipulation of bile acid availability, adoptive transfer of functional B cells, and ablation of bacterial <jats:italic>bile salt hydrolase<\/jats:italic> activity all influence the severity of small intestine enteropathy in CD19<jats:sup>\u2212\/\u2212<\/jats:sup> mice. Collectively, results from our experiments support a model whereby mucosal humoral immune responses limit inflammatory disease of the small bowel by regulating bacterial BA metabolism.<\/jats:p>","DOI":"10.1038\/s41467-022-28126-w","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:02:34Z","timestamp":1643194954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-8583","authenticated-orcid":false,"given":"Ahmed Dawood","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-8469","authenticated-orcid":false,"given":"Ioulia","family":"Chatzistamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0545-1137","authenticated-orcid":false,"given":"Amy","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian M.","family":"Schoettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-0070","authenticated-orcid":false,"given":"Andrew","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-8225","authenticated-orcid":false,"given":"Jason L.","family":"Kubinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"28126_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","volume":"18","author":"M Uzzan","year":"2016","unstructured":"Uzzan, M., Ko, H. M., Mehandru, S. & Cunningham-Rundles, C. Gastrointestinal disorders associated with common variable immune deficiency (CVID) and chronic granulomatous disease (CGD). Curr. Gastroenterol. Rep. 18, 17 (2016).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"28126_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/asheducation.V2012.1.301.3798316","volume":"2012","author":"C Cunningham-Rundles","year":"2012","unstructured":"Cunningham-Rundles, C. The many faces of common variable immunodeficiency. Hematology Am. Soc. Hematol. Educ. Program 2012, 301\u2013305 (2012).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"28126_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1023\/A:1012241117984","volume":"21","author":"C Cunningham-Rundles","year":"2001","unstructured":"Cunningham-Rundles, C. Physiology of IgA and IgA deficiency. J. Clin. Immunol. 21, 303\u2013309 (2001).","journal-title":"J. Clin. Immunol."},{"key":"28126_CR4","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","volume":"8","author":"JR Farmer","year":"2017","unstructured":"Farmer, J. R. et al. Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets. Front. Immunol. 8, 1740 (2017).","journal-title":"Front. Immunol."},{"key":"28126_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","volume":"11","author":"HE Ho","year":"2020","unstructured":"Ho, H. E. & Cunningham-Rundles, C. Non-infectious complications of common variable immunodeficiency: Updated clinical spectrum, sequelae, and insights to pathogenesis. Front. Immunol. 11, 149 (2020).","journal-title":"Front. Immunol."},{"key":"28126_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nri.2016.114","volume":"16","author":"JL Kubinak","year":"2016","unstructured":"Kubinak, J. L. & Round, J. L. Do antibodies select a healthy microbiota?. Nat. Rev. Immunol. 16, 767\u2013774 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"28126_CR7","doi-asserted-by":"publisher","unstructured":"Fadlallah, J. et al. Microbial ecology perturbation in human IgA deficiency. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan1217 (2018).","DOI":"10.1126\/scitranslmed.aan1217"},{"key":"28126_CR8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1084\/jem.20180427","volume":"215","author":"A Nakajima","year":"2018","unstructured":"Nakajima, A. et al. IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria. J. Exp. Med. 215, 2019\u20132034 (2018).","journal-title":"J. Exp. Med."},{"key":"28126_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1084\/jem.20160062","volume":"213","author":"J Loschko","year":"2016","unstructured":"Loschko, J. et al. Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation. J. Exp. Med. 213, 517\u2013534 (2016).","journal-title":"J. Exp. Med."},{"key":"28126_CR10","doi-asserted-by":"publisher","first-page":"e1008558","DOI":"10.1371\/journal.ppat.1008558","volume":"16","author":"MM Roland","year":"2020","unstructured":"Roland, M. M., Mohammed, A. D. & Kubinak, J. L. How MHCII signaling promotes benign host-microbiota interactions. PLoS Pathogens 16, e1008558 (2020).","journal-title":"PLoS Pathogens"},{"key":"28126_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.clim.2018.09.008","volume":"197","author":"N Shulzhenko","year":"2018","unstructured":"Shulzhenko, N. et al. CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont. Clin. Immunol. 197, 139\u2013153 (2018).","journal-title":"Clin. Immunol."},{"key":"28126_CR12","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/nm.2505","volume":"17","author":"N Shulzhenko","year":"2011","unstructured":"Shulzhenko, N. et al. Crosstalk between B lymphocytes, microbiota, and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585\u20131593 (2011).","journal-title":"Nat. Med."},{"key":"28126_CR13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2016.18","volume":"9","author":"SF Jorgensen","year":"2016","unstructured":"Jorgensen, S. F. et al. Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation. Mucosal Immunol. 9, 1455\u20131465 (2016).","journal-title":"Mucosal Immunol."},{"key":"28126_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F Backhed","year":"2005","unstructured":"Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915\u20131920 (2005).","journal-title":"Science"},{"key":"28126_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3389\/fmicb.2016.01165","volume":"7","author":"KD Kohl","year":"2016","unstructured":"Kohl, K. D. & Dearing, M. D. The woodrat gut microbiota as an experimental system for understanding microbial metabolism of dietary toxins. Front. Microbiol. 7, 1165 (2016).","journal-title":"Front. Microbiol."},{"key":"28126_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fphys.2019.00185","volume":"10","author":"N Molinero","year":"2019","unstructured":"Molinero, N., Ruiz, L., Sanchez, B., Margolles, A. & Delgado, S. Intestinal bacteria interplay with bile and cholesterol metabolism: Implications on host physiology. Front. Physiol. 10, 185 (2019).","journal-title":"Front. Physiol."},{"key":"28126_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1194\/jlr.R088989","volume":"60","author":"A Kriaa","year":"2019","unstructured":"Kriaa, A. et al. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J. Lipid Res. 60, 323\u2013332 (2019).","journal-title":"J. Lipid Res."},{"key":"28126_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22\u201339 (2016).","journal-title":"Gut Microbes"},{"key":"28126_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3748\/wjg.15.804","volume":"15","author":"MJ Monte","year":"2009","unstructured":"Monte, M. J., Marin, J. J., Antelo, A. & Vazquez-Tato, J. Bile acids: Chemistry, physiology, and pathophysiology. World J. Gastroenterol. 15, 804\u2013816 (2009).","journal-title":"World J. Gastroenterol."},{"key":"28126_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang, J. Y. Bile acid metabolism and signaling. Compr. Physiol. 3, 1191\u20131212 (2013).","journal-title":"Compr. Physiol."},{"key":"28126_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000450981","volume":"35","author":"JY Chiang","year":"2017","unstructured":"Chiang, J. Y. et al. Intestinal Farnesoid X receptor and Takeda G protein couple receptor 5 signaling in metabolic regulation. Dig. Dis. 35, 241\u2013245 (2017).","journal-title":"Dig. Dis."},{"key":"28126_CR22","doi-asserted-by":"publisher","first-page":"G81","DOI":"10.1152\/ajpgi.00065.2015","volume":"310","author":"AY Dossa","year":"2016","unstructured":"Dossa, A. Y. et al. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G81\u2013G92 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"28126_CR23","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1152\/physrev.00054.2017","volume":"98","author":"P Hegyi","year":"2018","unstructured":"Hegyi, P., Maleth, J., Walters, J. R., Hofmann, A. F. & Keely, S. J. Guts and Gall: Bile acids in regulation of intestinal epithelial function in health and disease. Physiol. Rev. 98, 1983\u20132023 (2018).","journal-title":"Physiol. Rev."},{"key":"28126_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song, X. et al. Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis. Nature 577, 410\u2013415 (2020).","journal-title":"Nature"},{"key":"28126_CR25","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci, S., Biagioli, M., Zampella, A. & Distrutti, E. Bile acids activated receptors regulate innate immunity. Front. Immunol. 9, 1853 (2018).","journal-title":"Front. Immunol."},{"key":"28126_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","volume":"30","author":"JM Ridlon","year":"2014","unstructured":"Ridlon, J. M., Kang, D. J., Hylemon, P. B. & Bajaj, J. S. Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30, 332\u2013338 (2014).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"28126_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241\u2013259 (2006).","journal-title":"J. Lipid Res."},{"key":"28126_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song, Z. et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut. Microbiome 7, 9 (2019).","journal-title":"Microbiome"},{"key":"28126_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","volume":"101","author":"C Staley","year":"2017","unstructured":"Staley, C., Weingarden, A. R., Khoruts, A. & Sadowsky, M. J. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl. Microbiol. Biotechnol. 101, 47\u201364 (2017).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"28126_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.tiv.2012.12.020","volume":"27","author":"JI Barrasa","year":"2013","unstructured":"Barrasa, J. I., Olmo, N., Lizarbe, M. A. & Turnay, J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol. In Vitro 27, 964\u2013977 (2013).","journal-title":"Toxicol. In Vitro"},{"key":"28126_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.14309\/ajg.0000000000000140","volume":"114","author":"S Pikkarainen","year":"2019","unstructured":"Pikkarainen, S. et al. A high prevalence of gastrointestinal manifestations in common variable immunodeficiency. Am. J. Gastroenterol. 114, 648\u2013655 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"28126_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/376352a0","volume":"376","author":"RC Rickert","year":"1995","unstructured":"Rickert, R. C., Rajewsky, K. & Roes, J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352\u2013355 (1995).","journal-title":"Nature"},{"key":"28126_CR33","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/1521-4141(200007)30:7<1861::AID-IMMU1861>3.0.CO;2-A","volume":"30","author":"E Gardby","year":"2000","unstructured":"Gardby, E. & Lycke, N. Y. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers, and IgA-isotype switching in Peyer\u2019s patches. Eur. J. Immunol. 30, 1861\u20131871 (2000).","journal-title":"Eur. J. Immunol."},{"key":"28126_CR34","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3389\/fimmu.2019.02484","volume":"10","author":"AD Mohammed","year":"2019","unstructured":"Mohammed, A. D. et al. Gut antibody deficiency in a mouse model of CVID results in spontaneous development of a gluten-sensitive enteropathy. Front. Immunol. 10, 2484 (2019).","journal-title":"Front. Immunol."},{"key":"28126_CR35","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.2741\/3399","volume":"14","author":"AF Hofmann","year":"2009","unstructured":"Hofmann, A. F. The enterohepatic circulation of bile acids in mammals: Form and functions. Front. Biosci. (Landmark Ed.) 14, 2584\u20132598 (2009).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"28126_CR36","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.bbamem.2013.05.021","volume":"1828","author":"J Mello-Vieira","year":"2013","unstructured":"Mello-Vieira, J. et al. Cytotoxic bile acids, but not cytoprotective species, inhibit the ordering effect of cholesterol in model membranes at physiologically active concentrations. Biochim. Biophys. Acta 1828, 2152\u20132163 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"28126_CR37","doi-asserted-by":"publisher","unstructured":"Van den Bossche, L. et al. Ursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice. Appl. Environ. Microbiol. https:\/\/doi.org\/10.1128\/AEM.02766-16 (2017).","DOI":"10.1128\/AEM.02766-16"},{"key":"28126_CR38","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/labinvest.2014.117","volume":"94","author":"D Laukens","year":"2014","unstructured":"Laukens, D. et al. Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death. Lab Invest. 94, 1419\u20131430 (2014).","journal-title":"Lab Invest."},{"key":"28126_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7453\/gahmj.2014.017","volume":"3","author":"S Vang","year":"2014","unstructured":"Vang, S., Longley, K., Steer, C. J. & Low, W. C. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Glob. Adv. Health Med. 3, 58\u201369 (2014).","journal-title":"Glob. Adv. Health Med."},{"key":"28126_CR40","doi-asserted-by":"publisher","first-page":"e16683","DOI":"10.1371\/journal.pone.0016683","volume":"6","author":"YK Zhang","year":"2011","unstructured":"Zhang, Y. K., Guo, G. L. & Klaassen, C. D. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PLoS One 6, e16683 (2011).","journal-title":"PLoS One"},{"key":"28126_CR41","doi-asserted-by":"publisher","unstructured":"Yao, L. et al. A selective gut bacterial bile salt hydrolase alters host metabolism. Elife https:\/\/doi.org\/10.7554\/eLife.37182 (2018).","DOI":"10.7554\/eLife.37182"},{"key":"28126_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2567.2010.03318.x","volume":"131","author":"Y Mishima","year":"2010","unstructured":"Mishima, Y. et al. Decreased production of interleukin-10 and transforming growth factor-beta in Toll-like receptor-activated intestinal B cells in SAMP1\/Yit mice. Immunology 131, 473\u2013487 (2010).","journal-title":"Immunology"},{"key":"28126_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ajpath.2010.10.022","volume":"178","author":"K Yanaba","year":"2011","unstructured":"Yanaba, K. et al. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178, 735\u2013743 (2011).","journal-title":"Am. J. Pathol."},{"key":"28126_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.MIB.0000437983.14544.d5","volume":"20","author":"A Oka","year":"2014","unstructured":"Oka, A. et al. Role of regulatory B cells in chronic intestinal inflammation: Association with pathogenesis of Crohn\u2019s disease. Inflamm. Bowel Dis. 20, 315\u2013328 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"28126_CR45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0022-2275(20)38331-0","volume":"30","author":"DM Heuman","year":"1989","unstructured":"Heuman, D. M. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res. 30, 719\u2013730 (1989).","journal-title":"J Lipid Res."},{"key":"28126_CR46","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0022-2275(20)41426-9","volume":"33","author":"AF Hofmann","year":"1992","unstructured":"Hofmann, A. F. & Mysels, K. J. Bile acid solubility and precipitation in vitro and in vivo: The role of conjugation, pH, and Ca2+ ions. J. Lipid Res. 33, 617\u2013626 (1992).","journal-title":"J. Lipid Res."},{"key":"28126_CR47","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","volume":"111","author":"SA Joyce","year":"2014","unstructured":"Joyce, S. A. et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc. Natl Acad. Sci. USA 111, 7421\u20137426 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28126_CR48","first-page":"112","volume":"3","author":"AC Dukowicz","year":"2007","unstructured":"Dukowicz, A. C., Lacy, B. E. & Levine, G. M. Small intestinal bacterial overgrowth: A comprehensive review. Gastroenterol. Hepatol. 3, 112\u2013122 (2007).","journal-title":"Gastroenterol. Hepatol."},{"key":"28126_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/gut.42.2.154","volume":"42","author":"GM Murphy","year":"1998","unstructured":"Murphy, G. M. Depressing acid, deconjugating bile. Gut 42, 154\u2013155 (1998).","journal-title":"Gut"},{"key":"28126_CR50","first-page":"462","volume":"44","author":"K Shindo","year":"1996","unstructured":"Shindo, K., Yamazaki, R., Koide, K., Fukumura, M. & Hirai, Y. Alteration of bile acid metabolism by cimetidine in healthy humans. J. Investig. Med. 44, 462\u2013469 (1996).","journal-title":"J. Investig. Med."},{"key":"28126_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/gut.42.2.266","volume":"42","author":"K Shindo","year":"1998","unstructured":"Shindo, K., Machida, M., Fukumura, M., Koide, K. & Yamazaki, R. Omeprazole induces altered bile acid metabolism. Gut 42, 266\u2013271 (1998).","journal-title":"Gut"},{"key":"28126_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41589-020-0467-3","volume":"16","author":"AA Adhikari","year":"2020","unstructured":"Adhikari, A. A. et al. Development of a covalent inhibitor of gut bacterial bile salt hydrolases. Nat. Chem. Biol. 16, 318\u2013326 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"28126_CR53","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3945\/jn.113.180810","volume":"143","author":"LK Stenman","year":"2013","unstructured":"Stenman, L. K., Holma, R., Forsgard, R., Gylling, H. & Korpela, R. Higher fecal bile acid hydrophobicity is associated with exacerbation of dextran sodium sulfate colitis in mice. J. Nutr. 143, 1691\u20131697 (2013).","journal-title":"J. Nutr."},{"key":"28126_CR54","first-page":"1931","volume":"10","author":"Y Araki","year":"2003","unstructured":"Araki, Y. et al. The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol. Rep. 10, 1931\u20131936 (2003).","journal-title":"Oncol. Rep."},{"key":"28126_CR55","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1101\/gr.131482.111","volume":"22","author":"SJ Pamp","year":"2012","unstructured":"Pamp, S. J., Harrington, E. D., Quake, S. R., Relman, D. A. & Blainey, P. C. Single-cell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB). Genome Res. 22, 1107\u20131119 (2012).","journal-title":"Genome Res."},{"key":"28126_CR56","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fphys.2012.00448","volume":"3","author":"F Carbonero","year":"2012","unstructured":"Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H. & Gaskins, H. R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 3, 448 (2012).","journal-title":"Front. Physiol."},{"key":"28126_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","volume":"579","author":"RA Quinn","year":"2020","unstructured":"Quinn, R. A. et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579, 123\u2013129 (2020).","journal-title":"Nature"},{"key":"28126_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2217\/clp.12.12","volume":"7","author":"J Chan","year":"2012","unstructured":"Chan, J. & Vandeberg, J. L. Hepatobiliary transport in health and disease. Clin. Lipidol. 7, 189\u2013202 (2012).","journal-title":"Clin. Lipidol."},{"key":"28126_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","volume":"58","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic, E., Claudel, T. & Trauner, M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J. Hepatol. 58, 155\u2013168 (2013).","journal-title":"J. Hepatol."},{"key":"28126_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha, S. R. et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27, 659\u2013670 e655 (2020).","journal-title":"Cell Host Microbe"},{"key":"28126_CR61","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jaci.2009.06.018","volume":"124","author":"S Agarwal","year":"2009","unstructured":"Agarwal, S. & Mayer, L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J. Allergy Clin. Immunol. 124, 658\u2013664 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"28126_CR62","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/ajg.2010.214","volume":"105","author":"G Malamut","year":"2010","unstructured":"Malamut, G. et al. The enteropathy associated with common variable immunodeficiency: The delineated frontiers with celiac disease. Am. J. Gastroenterol. 105, 2262\u20132275 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"28126_CR63","doi-asserted-by":"publisher","first-page":"e0183564","DOI":"10.1371\/journal.pone.0183564","volume":"12","author":"M DiMarzio","year":"2017","unstructured":"DiMarzio, M. et al. Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-beta-MCA. PLoS One 12, e0183564 (2017).","journal-title":"PLoS One"},{"key":"28126_CR64","doi-asserted-by":"publisher","unstructured":"O\u2019Flaherty, S., Briner Crawley, A., Theriot, C. M. & Barrangou, R. The lactobacillus bile salt hydrolase repertoire reveals niche-specific adaptation. mSphere https:\/\/doi.org\/10.1128\/mSphere.00140-18 (2018).","DOI":"10.1128\/mSphere.00140-18"},{"key":"28126_CR65","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.3748\/wjg.v20.i38.13999","volume":"20","author":"C Sanchez-Montes","year":"2014","unstructured":"Sanchez-Montes, C. et al. Small intestinal bacterial overgrowth in inactive Crohn\u2019s disease: Influence of thiopurine and biological treatment. World J. Gastroenterol. 20, 13999\u201314003 (2014).","journal-title":"World J. Gastroenterol."},{"key":"28126_CR66","doi-asserted-by":"publisher","unstructured":"Losurdo, G. et al. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis. Neurogastroenterol. Motil. https:\/\/doi.org\/10.1111\/nmo.13028 (2017).","DOI":"10.1111\/nmo.13028"},{"key":"28126_CR67","first-page":"1295","volume":"9","author":"V Kumar","year":"2002","unstructured":"Kumar, V. et al. Celiac disease and immunoglobulin a deficiency: How effective are the serological methods of diagnosis? Clin. Diagn. Lab Immunol. 9, 1295\u20131300 (2002).","journal-title":"Clin. Diagn. Lab Immunol."},{"key":"28126_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fped.2018.00389","volume":"6","author":"M Torsten","year":"2018","unstructured":"Torsten, M. & Aaron, L. Microbial transglutaminase is immunogenic and potentially pathogenic in pediatric celiac disease. Front. Pediatr. 6, 389 (2018).","journal-title":"Front. Pediatr."},{"key":"28126_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4, 2384 (2013).","journal-title":"Nat. Commun."},{"key":"28126_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"key":"28126_CR71","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"28126_CR72","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814\u2013821 (2013).","journal-title":"Nat. Biotechnol."},{"key":"28126_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"28126_CR74","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben, U. et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int. J. Clin. Exp. Pathol. 7, 4557\u20134576 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28126-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:08:27Z","timestamp":1669306107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28126-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28126"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28126-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"525"}}